GE Healthcare’s deci­sion to move poten­tially hun­dreds of jobs to Mass­a­chu­setts — and the already-​​existing cluster of major life sci­ences com­pa­nies — could help reduce health care costs and create greater access to cutting-​​edge med­ical tech­nology in the Bay State, an expert told the Herald.

Having these com­pa­nies close by where research staff are studying these dis­eases, it prob­ably means our hos­pi­tals remain on the cut­ting edge of med­i­cine,” said Barry Blue­stone of North­eastern Uni­ver­sity. “So when a break­through comes and it’s FDA approved, the first who get to use it are prob­ably patients in the Boston area. We prob­ably do ben­efit — by being the first adopters of new med­ical breakthroughs.”

Read the article at Boston Herald →